sulfadiazine

Sulfadiazine (Sulphadiazine) is a synthetic pyrimidinyl sulfonamide derivative, short-acting bacteriostatic Sulfadiazine inhibits bacterial folic acid synthesis by competing with para-aminobenzoic acid. It is used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.

Silver sulfadiazine (Dermazin) is a sulfonamide-based topical agent with antibacterial and antifungal activity.

Sulfadiazine sodium (Sulfadiazin-natrium) is a sodium salt form of sulfadiazine, an intermediate-acting bacteriostatic, synthetic sulfanilamide derivative.

Sulfadiazine D4 is a deuterium labeled Sulfadiazine. Sulfadiazine used for the treatment of toxoplasmosis.

Sulfadiazine BSA is an antigen-adjuvant conjugate of Sulfadiazine with bovine serum albumin (BSA). By conjugating antigens with a protein adjuvant, it enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or alter major epitopes and can boost cross-presentation and antigen-specific T cell production.

Glycodiazine is a sulfadiazine derivative with antihyperglycemic activity. Glycanamidine can lower blood sugar levels by increasing insulin release from pancreatic beta cells and increasing peripheral tissue sensitivity to insulin.